HT
MRNA icon

HAP Trading’s Moderna MRNA Stock Holding History

HAP Trading’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$109K Buy
+11,900
New +$332K 0.01% 481
2025
Q2 		– Sell
-13,400
Closed -$155K – 844
2025
Q1 		$155K Buy
+13,400
New +$476K 0.02% 342
2024
Q4 		– Sell
-27,400
Closed -$642K – 806
2024
Q3 		$642K Buy
27,400
+7,500
+38% +$689K 0.07% 161
2024
Q2 		$145K Hold
19,900
– – 0.02% 325
2024
Q1 		$211K Sell
19,900
-41,500
-68% -$4.18M 0.02% 292
2023
Q4 		$469K Buy
61,400
+50,000
+439% +$4.21M 0.07% 200
2023
Q3 		$157K Buy
11,400
+1,300
+13% +$145K 0.03% 328
2023
Q2 		$129K Buy
+10,100
New +$1.35M 0.02% 345
2023
Q1 		– Sell
-30,700
Closed -$159K – 1506
2022
Q4 		$159K Buy
30,700
+10,000
+48% +$1.64M 0.02% 507
2022
Q3 		$413K Buy
20,700
+1,200
+6% +$182K 0.03% 397
2022
Q2 		$457K Sell
19,500
-44,500
-70% -$6.36M 0.02% 471
2022
Q1 		$2.81M Sell
64,000
-23,300
-27% -$3.92M 0.12% 157
2021
Q4 		$2.21M Sell
87,300
-1,000
-1% -$292K 0.06% 283
2021
Q3 		$1.74M Buy
88,300
+6,500
+8% +$2.4M 0.06% 310
2021
Q2 		$103K Buy
81,800
+6,700
+9% +$1.2M ﹤0.01% 1213
2021
Q1 		$724K Sell
75,100
-1,800
-2% -$261K 0.04% 388
2020
Q4 		$917K Buy
76,900
+23,000
+43% +$2.33M 0.03% 437
2020
Q3 		$224K Sell
53,900
-28,000
-34% -$1.95M 0.01% 604
2020
Q2 		$161K Buy
81,900
+69,500
+560% +$3.81M 0.01% 745
2020
Q1 		$40K Buy
+12,400
New +$285K ﹤0.01% 815

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

HAP Trading's MRNA Position: Q1 2024 in Review

HAP Trading sold out of Moderna (MRNA) in Q1 2024, closing a stake of 14,736 shares — an estimated $1.49M sold.

HAP Trading first reported a position in MRNA in Q3 2019 and held it in 9 quarters. The position peaked at $10.4M in Q2 2021. 903 funds tracked by Wall St. Rank hold MRNA as of Q1 2024.

  • HAP Trading reported no remaining Moderna position as of Q1 2024 after selling out during the quarter.
  • HAP Trading sold 14,736 Moderna shares in Q1 2024, an estimated $1.49M.
  • HAP Trading first reported a position in Moderna in Q3 2019 and held it in 9 quarters.
  • HAP Trading's Moderna position peaked at $10.4M in Q2 2021.
  • 903 funds tracked by Wall St. Rank held Moderna as of Q1 2024.

Based on HAP Trading's 13F filing for Q1 2024, filed 13 May 2024.